Objective: Resistance to immune checkpoint inhibitors (ICIs) has been a massive obstacle to ICI treatment in metastatic urothelial carcinoma (MUC). Recently. increasing evidence indicates the clinical importance of the association between hypoxia and immune status in tumor patients. Therefore. https://www.bekindtopets.com/limited-price-PGH-The-Perfect-Garden-Hose-hot-value/